Cargando…

Design of the HPTN 065 (TLC-Plus) study: A study to evaluate the feasibility of an enhanced test, link-to-care, plus treat approach for HIV prevention in the United States

BACKGROUND/AIMS: HIV continues to be a major public health threat in the United States, and mathematical modeling has demonstrated that the universal effective use of antiretroviral therapy among all HIV-positive individuals (i.e. the “test and treat” approach) has the potential to control HIV. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Gamble, Theresa, Branson, Bernard, Donnell, Deborah, Hall, H Irene, King, Georgette, Cutler, Blayne, Hader, Shannon, Burns, David, Leider, Jason, Wood, Angela Fulwood, G. Volpp, Kevin, Buchacz, Kate, El-Sadr, Wafaa M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639958/
https://www.ncbi.nlm.nih.gov/pubmed/28627929
http://dx.doi.org/10.1177/1740774517711682
_version_ 1783270958550745088
author Gamble, Theresa
Branson, Bernard
Donnell, Deborah
Hall, H Irene
King, Georgette
Cutler, Blayne
Hader, Shannon
Burns, David
Leider, Jason
Wood, Angela Fulwood
G. Volpp, Kevin
Buchacz, Kate
El-Sadr, Wafaa M
author_facet Gamble, Theresa
Branson, Bernard
Donnell, Deborah
Hall, H Irene
King, Georgette
Cutler, Blayne
Hader, Shannon
Burns, David
Leider, Jason
Wood, Angela Fulwood
G. Volpp, Kevin
Buchacz, Kate
El-Sadr, Wafaa M
author_sort Gamble, Theresa
collection PubMed
description BACKGROUND/AIMS: HIV continues to be a major public health threat in the United States, and mathematical modeling has demonstrated that the universal effective use of antiretroviral therapy among all HIV-positive individuals (i.e. the “test and treat” approach) has the potential to control HIV. However, to accomplish this, all the steps that define the HIV care continuum must be achieved at high levels, including HIV testing and diagnosis, linkage to and retention in clinical care, antiretroviral medication initiation, and adherence to achieve and maintain viral suppression. The HPTN 065 (Test, Link-to-Care Plus Treat [TLC-Plus]) study was designed to determine the feasibility of the “test and treat” approach in the United States. METHODS: HPTN 065 was conducted in two intervention communities, Bronx, NY, and Washington, DC, along with four non-intervention communities, Chicago, IL; Houston, TX; Miami, FL; and Philadelphia, PA. The study consisted of five components: (1) exploring the feasibility of expanded HIV testing via social mobilization and the universal offer of testing in hospital settings, (2) evaluating the effectiveness of financial incentives to increase linkage to care, (3) evaluating the effectiveness of financial incentives to increase viral suppression, (4) evaluating the effectiveness of a computer-delivered intervention to decrease risk behavior in HIV-positive patients in healthcare settings, and (5) administering provider and patient surveys to assess knowledge and attitudes regarding the use of antiretroviral therapy for prevention and the use of financial incentives to improve health outcomes. The study used observational cohorts, cluster and individual randomization, and made novel use of the existing national HIV surveillance data infrastructure. All components were developed with input from a community advisory board, and pragmatic methods were used to implement and assess the outcomes for each study component. RESULTS: A total of 76 sites in Washington, DC, and the Bronx, NY, participated in the study: 37 HIV test sites, including 16 hospitals, and 39 HIV care sites. Between September 2010 and December 2014, all study components were successfully implemented at these sites and resulted in valid outcomes. Our pragmatic approach to the study design, implementation, and the assessment of study outcomes allowed the study to be conducted within established programmatic structures and processes. In addition, it was successfully layered on the ongoing standard of care and existing data infrastructure without disrupting health services. CONCLUSION: The HPTN 065 study demonstrated the feasibility of implementing and evaluating a multi-component “test and treat” trial that included a large number of community sites and involved pragmatic approaches to study implementation and evaluation.
format Online
Article
Text
id pubmed-5639958
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-56399582017-10-26 Design of the HPTN 065 (TLC-Plus) study: A study to evaluate the feasibility of an enhanced test, link-to-care, plus treat approach for HIV prevention in the United States Gamble, Theresa Branson, Bernard Donnell, Deborah Hall, H Irene King, Georgette Cutler, Blayne Hader, Shannon Burns, David Leider, Jason Wood, Angela Fulwood G. Volpp, Kevin Buchacz, Kate El-Sadr, Wafaa M Clin Trials Design BACKGROUND/AIMS: HIV continues to be a major public health threat in the United States, and mathematical modeling has demonstrated that the universal effective use of antiretroviral therapy among all HIV-positive individuals (i.e. the “test and treat” approach) has the potential to control HIV. However, to accomplish this, all the steps that define the HIV care continuum must be achieved at high levels, including HIV testing and diagnosis, linkage to and retention in clinical care, antiretroviral medication initiation, and adherence to achieve and maintain viral suppression. The HPTN 065 (Test, Link-to-Care Plus Treat [TLC-Plus]) study was designed to determine the feasibility of the “test and treat” approach in the United States. METHODS: HPTN 065 was conducted in two intervention communities, Bronx, NY, and Washington, DC, along with four non-intervention communities, Chicago, IL; Houston, TX; Miami, FL; and Philadelphia, PA. The study consisted of five components: (1) exploring the feasibility of expanded HIV testing via social mobilization and the universal offer of testing in hospital settings, (2) evaluating the effectiveness of financial incentives to increase linkage to care, (3) evaluating the effectiveness of financial incentives to increase viral suppression, (4) evaluating the effectiveness of a computer-delivered intervention to decrease risk behavior in HIV-positive patients in healthcare settings, and (5) administering provider and patient surveys to assess knowledge and attitudes regarding the use of antiretroviral therapy for prevention and the use of financial incentives to improve health outcomes. The study used observational cohorts, cluster and individual randomization, and made novel use of the existing national HIV surveillance data infrastructure. All components were developed with input from a community advisory board, and pragmatic methods were used to implement and assess the outcomes for each study component. RESULTS: A total of 76 sites in Washington, DC, and the Bronx, NY, participated in the study: 37 HIV test sites, including 16 hospitals, and 39 HIV care sites. Between September 2010 and December 2014, all study components were successfully implemented at these sites and resulted in valid outcomes. Our pragmatic approach to the study design, implementation, and the assessment of study outcomes allowed the study to be conducted within established programmatic structures and processes. In addition, it was successfully layered on the ongoing standard of care and existing data infrastructure without disrupting health services. CONCLUSION: The HPTN 065 study demonstrated the feasibility of implementing and evaluating a multi-component “test and treat” trial that included a large number of community sites and involved pragmatic approaches to study implementation and evaluation. SAGE Publications 2017-06-19 2017-08 /pmc/articles/PMC5639958/ /pubmed/28627929 http://dx.doi.org/10.1177/1740774517711682 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution 4.0 License (http://www.creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).
spellingShingle Design
Gamble, Theresa
Branson, Bernard
Donnell, Deborah
Hall, H Irene
King, Georgette
Cutler, Blayne
Hader, Shannon
Burns, David
Leider, Jason
Wood, Angela Fulwood
G. Volpp, Kevin
Buchacz, Kate
El-Sadr, Wafaa M
Design of the HPTN 065 (TLC-Plus) study: A study to evaluate the feasibility of an enhanced test, link-to-care, plus treat approach for HIV prevention in the United States
title Design of the HPTN 065 (TLC-Plus) study: A study to evaluate the feasibility of an enhanced test, link-to-care, plus treat approach for HIV prevention in the United States
title_full Design of the HPTN 065 (TLC-Plus) study: A study to evaluate the feasibility of an enhanced test, link-to-care, plus treat approach for HIV prevention in the United States
title_fullStr Design of the HPTN 065 (TLC-Plus) study: A study to evaluate the feasibility of an enhanced test, link-to-care, plus treat approach for HIV prevention in the United States
title_full_unstemmed Design of the HPTN 065 (TLC-Plus) study: A study to evaluate the feasibility of an enhanced test, link-to-care, plus treat approach for HIV prevention in the United States
title_short Design of the HPTN 065 (TLC-Plus) study: A study to evaluate the feasibility of an enhanced test, link-to-care, plus treat approach for HIV prevention in the United States
title_sort design of the hptn 065 (tlc-plus) study: a study to evaluate the feasibility of an enhanced test, link-to-care, plus treat approach for hiv prevention in the united states
topic Design
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639958/
https://www.ncbi.nlm.nih.gov/pubmed/28627929
http://dx.doi.org/10.1177/1740774517711682
work_keys_str_mv AT gambletheresa designofthehptn065tlcplusstudyastudytoevaluatethefeasibilityofanenhancedtestlinktocareplustreatapproachforhivpreventionintheunitedstates
AT bransonbernard designofthehptn065tlcplusstudyastudytoevaluatethefeasibilityofanenhancedtestlinktocareplustreatapproachforhivpreventionintheunitedstates
AT donnelldeborah designofthehptn065tlcplusstudyastudytoevaluatethefeasibilityofanenhancedtestlinktocareplustreatapproachforhivpreventionintheunitedstates
AT hallhirene designofthehptn065tlcplusstudyastudytoevaluatethefeasibilityofanenhancedtestlinktocareplustreatapproachforhivpreventionintheunitedstates
AT kinggeorgette designofthehptn065tlcplusstudyastudytoevaluatethefeasibilityofanenhancedtestlinktocareplustreatapproachforhivpreventionintheunitedstates
AT cutlerblayne designofthehptn065tlcplusstudyastudytoevaluatethefeasibilityofanenhancedtestlinktocareplustreatapproachforhivpreventionintheunitedstates
AT hadershannon designofthehptn065tlcplusstudyastudytoevaluatethefeasibilityofanenhancedtestlinktocareplustreatapproachforhivpreventionintheunitedstates
AT burnsdavid designofthehptn065tlcplusstudyastudytoevaluatethefeasibilityofanenhancedtestlinktocareplustreatapproachforhivpreventionintheunitedstates
AT leiderjason designofthehptn065tlcplusstudyastudytoevaluatethefeasibilityofanenhancedtestlinktocareplustreatapproachforhivpreventionintheunitedstates
AT woodangelafulwood designofthehptn065tlcplusstudyastudytoevaluatethefeasibilityofanenhancedtestlinktocareplustreatapproachforhivpreventionintheunitedstates
AT gvolppkevin designofthehptn065tlcplusstudyastudytoevaluatethefeasibilityofanenhancedtestlinktocareplustreatapproachforhivpreventionintheunitedstates
AT buchaczkate designofthehptn065tlcplusstudyastudytoevaluatethefeasibilityofanenhancedtestlinktocareplustreatapproachforhivpreventionintheunitedstates
AT elsadrwafaam designofthehptn065tlcplusstudyastudytoevaluatethefeasibilityofanenhancedtestlinktocareplustreatapproachforhivpreventionintheunitedstates
AT designofthehptn065tlcplusstudyastudytoevaluatethefeasibilityofanenhancedtestlinktocareplustreatapproachforhivpreventionintheunitedstates